Clinical Trials Logo

Filter by:
NCT ID: NCT04117230 Recruiting - Cardiogenic Shock Clinical Trials

CARDSUP - SWISS Circulatory Support Registry

CARDSUP
Start date: August 9, 2019
Phase:
Study type: Observational [Patient Registry]

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All patients undergoing ECMO and/or IMPELLA implantation will be prospectively registered. Device use is according to the decision of the treating physician and independent of this registry.

NCT ID: NCT04116294 Recruiting - Clinical trials for Plain Abdominal Radiography

Using a Computer-assisted Prescription to Decrease Inappropriate Use of Plain Abdominal Radiography in Emergency Department

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to assess whether a computer-assisted prescription allows a reduction of the overall number of inappropriate PAR in emergency departments.

NCT ID: NCT04116242 Recruiting - Liver Disease Clinical Trials

MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease

Start date: August 27, 2015
Phase:
Study type: Observational

This study is to investigate MER receptor tyrosine kinase (MERTK) signalling cascade on monocytes and tissue macrophages in respect to innate immune function of the cells in patients with cirrhosis at different stages of disease (Child A, B, C, acute decompensation, acute-on-chronic liver failure (ACLF)) and in comparison to patients with acute liver failure and to healthy controls.

NCT ID: NCT04111978 Recruiting - Clinical trials for Peritoneal Neoplasms

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

MATAO
Start date: November 5, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of addition of letrozole to the standard maintenance therapy in subjects following a primary diagnosis of Estrogen-receptor (ER) positive high and low grade epithelial ovarian cancer (including fallopian tube and primary peritoneal cancer) and subsequent primary treatment surgery and chemotherapy. Half of the participants will receive to the standard maintenance treatment, letrozole, whilst the other half receives placebo. The study's primary hypothesis is that the treatment with letrozole increases progression free survival in comparison to the maintenance standard treatment (superiority trial).

NCT ID: NCT04111315 Recruiting - Low Back Pain Clinical Trials

Efficacy of Metamizole Versus Ibuprofen and a Short Educational Intervention Versus Standard Care in Acute Low Back Pain

EMISI
Start date: December 15, 2019
Phase: Phase 4
Study type: Interventional

The EMISI trial is a randomized, double blind, controlled trial (RCT) using a factorial design in patients with a new low back pain episode. The study aims to assess (A) whether metamizole, a non-opioid drug approved in Switzerland for pain treatment, is non-inferior to ibuprofen in a new episode of acute or subacute LBP and (B) whether a short educational intervention including evidence-based patient information is superior to usual care alone. Despite its increased use, the role of metamizole for the treatment of LBP is unclear and has so far not been systematically studied.

NCT ID: NCT04110821 Recruiting - Quality of Life Clinical Trials

Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse

LOLIPOP
Start date: September 15, 2019
Phase:
Study type: Observational [Patient Registry]

This is an observational study that gives baseline and follow-up information, that does not directly influence the allocation of patients to various treatment Options (conservative and surgical therapy of Pelvic Organ Prolapse) but the knowledge gained of the data will help to develop treatment strategies.

NCT ID: NCT04109755 Recruiting - Rectal Cancer Clinical Trials

Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer

PEMREC
Start date: June 2, 2020
Phase: Phase 2
Study type: Interventional

This project investigates the clinical and biological impact of combining immunotherapy (pembrolizumab) with short course radiotherapy (5Gy, five times) in the neo-adjuvant treatment of localised microsatellite stable (MSS) rectal cancer.

NCT ID: NCT04108741 Recruiting - Parkinson Disease Clinical Trials

Augmented Reality Treadmill Training in Patients With Parkinson's Disease

Falls_in_PD
Start date: September 15, 2020
Phase: N/A
Study type: Interventional

Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients during the course. Three methods of treadmill training (TT) will be compared to assess additional augmented reality (AR), or additional dual task (DT). AR TT, DT TT, and TT alone applied over 3 weeks at each day will be compared for their impact on falls, walking, freezing and attention for 3 months in a double blinded randomized controlled trial during regular neurorehabilitation.

NCT ID: NCT04100213 Recruiting - Clinical trials for Stress, Psychological

Real-Time Assessment of Stress and Stress Response

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

Stress is a complex natural phenomenon, frequently related to a physiological response, including heart rate, heart rate variability, respiratory rate, skin conductance and temperature. The subjective experience varies greatly; broadly, it may be conceived as a freeze, flight, fight, fright or faint response. Many studies have demonstrated the negative influence of psychological stress on health and well-being. Through the digital phenotyping of physiological and psychological stress reactions, in a controlled laboratory setting (Trier Social Stress Test- TSST) and real-life situations, in a population of healthy participants and patients with a major psychiatric disorder, we expect to find reliable and valid digital biomarkers. The results of this study will, therefore, not only contribute to a better understanding of stress and stress response but also have the potential to improve diagnostic and treatment approaches.

NCT ID: NCT04099940 Recruiting - Schizophrenia Clinical Trials

Virtual Reality Avatar Therapy for People Hearing Voices

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Hearing voices is probably the worst form of acoustic hallucinations; which can be experienced as severely disturbing and is influenced by diverse factors including the ability of the individual to influence and control the hallucinatory experience itself. In recent years virtual reality has become a treatment option. In the so-called AVATAR Therapy, patients with schizophrenia and acoustic hallucinations design a visual and auditory recreation (avatar) of the entity to which they attribute their hallucinations. Working with a therapist over the course of several sessions, participants change the avatar from controlling to benevolent. Avatar Therapy involves similar processes to learning and cognitive restructuring, comparable to other psychotherapeutic interventions. The investigators plan to conduct an interventional study using a cross-over design, to compare the feasibility and efficacy of virtual reality avatar therapy for patients with acoustic hallucinations (independent of psychiatric diagnosis) with a cognitive behavioural group therapy aimed to improve social competence.